Product Details

Second Wave of Sponsor, CRO Growth Hitting Asia-Pac

A second wave of pharma is establishing R&D centers in China and top 10 pharmas are expanding their existing centers, spurring CROs to get busy not only in China but the entire Asia-Pac region.

FDA Guidance Boosts ePRO

The final patient-reported out- come guidance (PRO) from the FDA goes farther than any other FDA document in recognizing the role of interactive voice response (IVR), computer-based patient diaries and other electronic patient-reported outcome technologies.

IQWiG Calls for Mandatory Clinical Trial Transparency in EU

The Institute for Quality and Efficiency in Health Care (IQWiG) recently called upon the German government to push for a regulation to be implemented at the EU level requiring the registration and publication of all clinical trial results to be made mandatory, rather than voluntary.

Eye On: Bipolar Disorder, Depression and Anxiety

Mood disorders are highly prevalent in today’s society. At least 121 million people worldwide suffer from depression, according to the World Health Organization, and in the Western world, 20% of the population will have depression during their lifetime. Among U.S. adults ages 18 to 54, prevalence of all anxiety disorders is more than 16%, according to the U.S. Surgeon General.

• Month in Review
• In the Pipeline
• Opportunities Initiating
• TrialWatch